97
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Effect of Aegle marmelos on DEN initiated and 2-AAF promoted hepatocarcinogenesis: a chemopreventive study

&
Pages 453-462 | Received 22 Jan 2011, Accepted 16 Feb 2011, Published online: 21 Mar 2011

References

  • Aggarwal BB, Danda D, Gupta S, Gehlot P. 2009. Models for prevention and treatment of cancer: problems vs promises. Biochem Pharmacol 78:1083–1094.
  • Ahmed S, Rahman A, Mathur M, Athar M, Sultana S. 2001. Anti-tumor promoting activity of Asteracantha longifolia against experimental hepatocarcinogenesis in rats. Food Chem Toxicol 39:19–28.
  • Alam A, Khan N, Sharma S, Saleem M, Sultana S. 2002. Chemopreventive effect of Vitis vinifera extract on 12-O-tetradecanoyl-13-phorbol acetate-induced cutaneous oxidative stress and tumor promotion in murine skin. Pharmacol Res 46:557–564.
  • Aruoma OI. 2003. Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutat Res 523-524:9–20.
  • Athar M, Iqbal M. 1998. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis 19:1133–1139.
  • Auvinen M, Laine A, Paasinen-Sohns A, Kangas A, Kangas L, Saksela O, Andersson LC, Hölttä E. 1997. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res 57:3016–3025.
  • Best DH, Coleman WB. 2007. Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats. J Hepatol 46:1055–1063.
  • Bitsch A, Hadjiolov N, Klöhn PC, Bergmann O, Zwirner-Baier I, Neumann HG. 2000. Dose response of early effects related to tumor promotion of 2-acetylaminofluorene. Toxicol Sci 55:44–51.
  • Bitsch A, Klöhn PC, Hadjiolov N, Bergmann O, Neumann HG. 1999. New insights into carcinogenesis of the classical model arylamine 2-acetylaminofluorene. Cancer Lett 143:223–227.
  • Carlberg I, Mannervik B. 1975. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480.
  • Cikryt P, Göttlicher M, Neumann HG. 1990. Competitive binding affinity of carcinogenic aromatic amines to the rat hepatic aromatic hydrocarbon (Ah) receptor in vitro and potency to induce monooxygenase activity in vivo. Carcinogenesis 11:1359–1366.
  • De Flora S, Ramel C. 1988. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res 202:285–306.
  • DiGiovanni J. 1992. Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63–128.
  • Doss MX, Potta SP, Hescheler J, Sachinidis A. 2005. Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J Nutr Biochem 16:259–266.
  • Farber E. (1984). Some emerging general principles in the pathogenesis of hepatocellular carcinoma. In: Farber E, ed. Experimental, Epidemiological and Clinical Aspects of Liver Carcinogenesis. Oxford: Oxford University Press.
  • Giles KW, Myers A. 1964. The role of nucleic acids in the growth of the hypocotyl of lupinus albus under varying light and dark regimes. Biochim Biophys Acta 87:460–477.
  • Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139.
  • Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57–70.
  • Hayashi S, Murakami Y. 1995. Rapid and regulated degradation of ornithine decarboxylase. Biochem J 306 (Pt 1):1–10.
  • Jeena KJ, Joy KL, Kuttan R. 1999. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett 136:11–16.
  • Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. 1974. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–169.
  • Parmar C, Kaushal MK. (1982). Aegle marmelos. In: Parmar C, Kaushal MK. (eds) Wild Fruits. New Delhi, India: Kalyani Publishers, pp. 1–5.
  • Kern MA, Breuhahn K, Schirmacher P. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Adv Cancer Res 86:67–112.
  • Khan N, Sharma S, Alam A, Saleem M, Sultana S. 2001. Tephrosia purpurea ameliorates N-diethylnitrosamine and potassium bromate-mediated renal oxidative stress and toxicity in Wistar rats. Pharmacol Toxicol 88:294–299.
  • Khan N, Sharma S, Sultana S. 2003. Nigella sativa (black cumin) ameliorates potassium bromate-induced early events of carcinogenesis: diminution of oxidative stress. Hum Exp Toxicol 22:193–203.
  • Khan N, Sultana S. 2005. Anticarcinogenic effect of Nymphaea alba against oxidative damage, hyperproliferative response and renal carcinogenesis in Wistar rats. Mol Cell Biochem 271:1–11.
  • Khan TH, Jahangir T, Prasad L, Sultana S. 2006. Inhibitory effect of apigenin on benzo(a)pyrene-mediated genotoxicity in Swiss albino mice. J Pharm Pharmacol 58:1655–1660.
  • Khan TH, Prasad L, Anuradha, Sultana S. 2005. Soy isoflavones inhibits the genotoxicity of benzo(a)pyrene in Swiss albino mice. Hum Exp Toxicol 24:149–155.
  • Khan TH, Sultana S. 2006. Apigenin induces apoptosis in Hep G2 cells: possible role of TNF-α and IFN-γ. Toxicology 217:206–212.
  • Khan TH, Sultana S. 2009. Antioxidant and hepatoprotective potential of Aegle marmelos Correa. against CCl4-induced oxidative stress and early tumor events. J Enzyme Inhib Med Chem 24:320–327.
  • Kirtikar KR, Basu BD. (1935). Indian Medicinal Plants, 2nd edn. Dehradun, India: B/S International Book Distributors, pp. 448–502.
  • Klöhn PC, Massalha H, Neumann HG. 1995. A metabolite of carcinogenic 2-acetylaminofluorene, 2-nitrosofluorene, induces redox cycling in mitochondria. Biochim Biophys Acta 1229:363–372.
  • Kojima T, Tanaka T, Kawamori T, Hara A, Mori H. 1993. Chemopreventive effects of dietary D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Cancer Res 53:3903–3907.
  • Kwon KH, Barve A, Yu S, Huang MT, Kong AN. 2007. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharmacol Sin 28:1409–1421.
  • Lee-Hilz YY, Boerboom AM, Westphal AH, Berkel WJ, Aarts JM, Rietjens IM. 2006. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol 19:1499–1505.
  • Loeb KR, Loeb LA. 2000. Significance of multiple mutations in cancer. Carcinogenesis 21:379–385.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
  • Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. 1984. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy. Biochem Pharmacol 33:1801–1807.
  • Morse MA, Stoner GD. 1993. Cancer chemoprevention: principles and prospects. Carcinogenesis 14:1737–1746.
  • Nadkarni AK. (1986). Dr. K.M. Nadkarni’s Indian Materia Medica. Vol.1. Bombay, India: Popular Prakashan Company.
  • Nakamura Y, Murakami A, Ohigashi H. 2000. Search for naturally-occurring antioxidative chemopreventors on the basis of the involvement of leukocyte-derived reactive oxygen species in carcinogenesis. Asian Pac J Cancer Prev 1:115–120.
  • O’Brien TG, Simsiman RC, Boutwell RK. 1975. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:1662–1670.
  • Pang RW, Poon RT. 2007. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72 Suppl 1:30–44.
  • Park CH, Hahm ER, Lee JH, Jung KC, Yang CH. 2005. Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells. Biochem Biophys Res Commun 331:1222–1228.
  • Park DY, Suh KS. 1999. Transforming growth factor-beta1 protein, proliferation and apoptosis of oval cells in acetylaminofluorene-induced rat liver regeneration. J Korean Med Sci 14:531–538.
  • Pegg AE, Shantz LM, Coleman CS. 1995. Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl 22:132–138.
  • Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA. 2009. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol Appl Pharmacol 235:305–311.
  • Prasad L, Khan TH, Sehrawat A, Sultana S. 2004. Modulatory effect of Morus indica against two-stage skin carcinogenesis in Swiss albino mice: possible mechanism by inhibiting aryl hydrocarbon hydroxylase. J Pharm Pharmacol 56:1291–1298.
  • Sanz N, Díez-Fernández C, Fernández-Simón L, Alvarez A, Cascales M. 1995. Relationship between antioxidant systems, intracellular thiols and DNA ploidy in liver of rats during experimental cirrhogenesis. Carcinogenesis 16:1585–1593.
  • Seow TK, Liang RC, Leow CK, Chung MC. 2001. Hepatocellular carcinoma: from bedside to proteomics. Proteomics 1:1249–1263.
  • Smart RC, Huang MT, Conney AH. 1986. sn-1,2-Diacylglycerols mimic the effects of 12-O-tetradecanoylphorbol-13-acetate in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis 7:1865–1870.
  • Solt DB, Farber E. (1976). New principles for the analysis of chemical carcinogenesis. Carcinogenesis 263:701–703.
  • Stirpe F, Della Corte E. 1969. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem 244:3855–3863.
  • Stoner GD, Mukhtar H. 1995. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 22:169–180.
  • Strom SC, Jirtle RL, Michalopoulos G. 1983. Genotoxic effects of 2-acetylaminofluorene on rat and human hepatocytes. Environ Health Perspect 49:165–170.
  • Sultana S, Ahmed S, Jahangir T. 2008. Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats. J Ethnopharmacol 118:1–6.
  • Tiwawech D, Hasegawa R, Kurata Y, Tatematsu M, Shibata MA, Thamavit W, Ito N. 1991. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis 12:985–990.
  • Van Gijssel HE, Ohlson LC, Torndal UB, Mulder GJ, Eriksson LC, Porsch-Hällström I, Meerman JH. 2000. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo. Hepatology 32:701–710.
  • Wattenberg LW. 1993. Prevention–therapy–basic science and the resolution of the cancer problem. Cancer Res 53:5890–5896.
  • Wilkinson J 4th, Clapper ML. 1997. Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med 216:192–200.
  • Wright JR, Colby HD, Miles PR. 1981. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 206:296–304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.